Clinical trial
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian…
NCT00043082 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00043082 |
|---|---|
| Title | S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer |
| Official title | A Phase III Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ovarian Cancer, Peritoneal Cavity Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, pegylated liposomal doxorubicin hydrochloride |
| Enrollment | 61 |
| Start date | Aug 1, 2002 |
| Primary completion | Jun 1, 2007 |
| Completion | Jul 1, 2011 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 26, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: